North Chicago, Illinois-based global biopharmaceutical company AbbVie (NYSE: ABBV) has presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult patients with moderate to severe atopic dermatitis
at the 2018 American Academy of Dermatology annual meeting, the company said.
Realm Therapeutics (AIM:RLM), a biopharmaceutical company has dosed the first patient in its phase two study of PR022, the Company's proprietary topical gel formulation of high concentration hypochlorous acid, intended for the treatment of atopic dermatitis
, it was reported yesterday.
Recent research into the pathophysiology of atopic dermatitis
has yielded two new treatments--the first ones to receive US Food and Drug Administration (FDA) approval for management of this condition in more than a decade.
Studies on adults with moderate to severe disease show that the symptoms and consequences of atopic dermatitis
affect many aspects of their lives.
is a very common skin disorder affecting millions of people worldwide.
The good news is, several drugs in the pipeline hold promise for atopic dermatitis
patients, thanks largely to emerging data on its pathophysiology.
But now, a better understanding of the underlying causes of atopic dermatitis
has opened the door to a targeted treatment that can address a critical factor behind atopic dermatitis
Additionally, the report provides an overview of key players involved in therapeutic development for Atopic dermatitis
and features dormant and discontinued projects.
This is the first study to examine the association between atopic dermatitis
and actinic keratosis [AK].
GlobalData epidemiologists forecast that the one-year total prevalent cases of atopic dermatitis
in the 9MM will increase from 66,289,178 cases in 2014 to 67,630,097 cases in 2024 with an annual growth rate (AGR) of 0.
Extrinsic and intrinsic types of atopic dermatitis
The exact mechanism by which Elidel exerts its effect in atopic dermatitis
is still unknown (Elidel prescribing information, 2011).